![Jack Higgins](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jack Higgins
Teknisk/Vetenskaplig/F&U Direktör på
IMMUNOME, INC.
Förmögenhet: 545 750 $ per 2026-05-31
Profil
Jack Higgins currently works at Immunome, Inc., as Chief Scientific Officer from 2023.
Dr. Higgins also formerly worked at Molecular Templates, Inc., as Chief Development Sciences Officer, Molecular Templates, Inc., as Chief Development Sciences Officer from 2019 to 2021, and MorphImmune, Inc., as Chief Scientific Officer from 2022 to 2023.
Dr. Higgins received his undergraduate degree from Texas A&M University and graduate degree and doctorate degree from The University of Arkansas.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNOME, INC. 0,02 % | 2026-04-02 | 25 000 ( 0,02 % ) | 545 750 $ | 2026-05-31 |
Aktiva positioner av Jack Higgins
| Företag | Position | Start |
|---|---|---|
| IMMUNOME, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-10-02 |
Tidigare kända positioner av Jack Higgins
| Företag | Position | Slut |
|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2023-10-01 |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Verksamhetschef | 2019-06-01 |
| MOLECULAR TEMPLATES, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Jack Higginss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
8
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Immunome, Inc.
 Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics | Health Technology |
Texas A&M University
 Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Arkansas
 The University of Arkansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Templates, Inc. /Old/
Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Discovers and develops immunotoxins for the treatment of cancer | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing oncology therapeutics | Health Technology |
